Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Therapeutic approach to eating disorders: the biological background.

Literature DB >> 19812751

Therapeutic approach to eating disorders: the biological background.

Palmiero Monteleone¹, Francesca Brambilla.

Abstract

Entities: Disease

Year: 2009 PMID： 19812751 PMCID： PMC2755279 DOI： 10.1002/j.2051-5545.2009.tb00242.x

Source DB: PubMed Journal: World Psychiatry ISSN： 1723-8617 Impact factor: 49.548

× No keyword cloud information.

12 in total

1. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.

Authors: W H Kaye; G K Frank; C C Meltzer; J C Price; C W McConaha; P J Crossan; K L Klump; L Rhodes
Journal: Am J Psychiatry Date: 2001-07 Impact factor: 18.112

2. The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.

Authors: Katherine A Halmi
Journal: Am J Psychiatry Date: 2008-10 Impact factor: 18.112

3. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.

Authors: Guido K Frank; Ursula F Bailer; Shannan E Henry; Wayne Drevets; Carolyn C Meltzer; Julie C Price; Chester A Mathis; Angela Wagner; Jessica Hoge; Scott Ziolko; Nicole Barbarich-Marsteller; Lisa Weissfeld; Walter H Kaye
Journal: Biol Psychiatry Date: 2005-06-29 Impact factor: 13.382

4. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.

Authors: Ursula F Bailer; Guido K Frank; Shannan E Henry; Julie C Price; Carolyn C Meltzer; Lisa Weissfeld; Chester A Mathis; Wayne C Drevets; Angela Wagner; Jessica Hoge; Scott K Ziolko; Claire W McConaha; Walter H Kaye
Journal: Arch Gen Psychiatry Date: 2005-09

5. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.

Authors: Ursula F Bailer; Guido K Frank; Shannan E Henry; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Angela Wagner; Laura Thornton; Jessica Hoge; Scott K Ziolko; Carl R Becker; Claire W McConaha; Walter H Kaye
Journal: Biol Psychiatry Date: 2007-01-22 Impact factor: 13.382

Therapeutic approach to eating disorders: the biological background.

1. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.

2. The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.

3. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride.

4. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.

5. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa.

6. Shared transmission of eating disorders and anxiety disorders.

7. Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach.

8. Altered dopamine activity after recovery from restricting-type anorexia nervosa.

9. Prevalence, heritability, and prospective risk factors for anorexia nervosa.

10. Diagnosis and management of binge eating disorder.

1. Salivary enzyme activity in anorexic persons—a controlled clinical trial.